Tadalafil monotherapy and as add-on to background bosentan in patients with pulmonary arterial hypertension

Tadalafil 40 mg was well-tolerated and provided clinical benefit in patients as monotherapy. It was also well-tolerated when added to background bosentan, but data are insufficient to conclude additional benefit.